Combination therapy for cancer using HSP27 inhibitor and EGFR tyrosine kinase inhibitors or anti-folates
- 专利权人:
- The University of British Columbia
- 发明人:
- Gleave, Martin E.,Zoubeidi, Amina,Kumano, Masafumi
- 申请号：
- AU2013216361
- 公开号：
- AU2013216361A1
- 申请日:
- 2013.02.01
- 申请国别(地区):
- AU
- 年份:
- 2014
- 代理人:
- 摘要：
- Combination therapy for cancer makes use of HSP27 inhibitors and EGFR tyrosine kinase inhibitors or antifolates.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION THERAPY FOR CANCER USING HSP27 INHIBITOR AND EGFR TYROSINE KINASE INHIBITORS OR ANTI-FOLATES
- COMBINATION THERAPY FOR CANCER USING HSP27 INHIBITOR AND EGFR TYROSINE KINASE INHIBITORS OR ANTI-FOLATES
- COMBINATION THERAPY FOR CANCER USING HSP27 INHIBITOR AND EGFR TYROSINE KINASE INHIBITORS OR ANTI-FOLATES
- COMBINATION THERAPY FOR CANCER USING HSP27 INHIBITOR AND EGFR TYROSINE KINASE INHIBITORS OR ANTI-FOLATES
